Revive Therapeutics Ltd
F:31R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revive Therapeutics Ltd
F:31R
|
CA |
|
S
|
StarHub Ltd
F:RYTB
|
SG |
|
Telefonaktiebolaget LM Ericsson
NASDAQ:ERIC
|
SE |
|
Bilfinger Se
F:GBFU
|
DE |
|
PSP Swiss Property AG
OTC:PSPSF
|
CH |
|
B
|
BCB Bhd
KLSE:BCB
|
MY |
|
Akora Resources Ltd
ASX:AKO
|
AU |
|
Quad/Graphics Inc
NYSE:QUAD
|
US |
|
T
|
Turbon AG
DUS:TUR
|
DE |
|
Terrain Minerals Ltd
ASX:TMX
|
AU |
Intrinsic Value
Is 31R undervalued or overvalued?
See the intrinsic value estimate for Revive Therapeutics Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
31R looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 31R’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Revive Therapeutics Does
Revive Therapeutics Ltd. is a development-stage biotechnology company that tries to turn existing drugs into new treatments for serious medical conditions. Its work centers on testing repurposed medicines and psychedelic-based therapies for areas such as infectious disease, inflammation, and mental health, where doctors still need better options. It does not run a broad consumer business; its main product is a pipeline of drug programs that are still being studied and advanced through the clinical and regulatory process.
- Headquarters
- Canada CA
- IPO date
- Jul 12, 2013
Revenue & Expenses Breakdown
Revive Therapeutics Ltd
Earnings Waterfall
Revive Therapeutics Ltd
The intrinsic value for Revive Therapeutics Ltd (31R) under the Base Case is hidden EUR.
Compared with the current market price of 0.011 EUR, the stock appears hidden.